P. Kanda et al., DEPENDENCE OF THE MURINE-ANTIBODY RESPONSE TO AN ANTI-CD4 CDR2 V-H PEPTIDE ON IMMUNOGEN FORMULATION, Molecular immunology, 32(17-18), 1995, pp. 1319-1328
A peptide corresponding to the second complementarity determining regi
on of the heavy chain (CDR2 V-H) from a murine anti-CD4 monoclonal ant
ibody, designated L202, was synthesized by solid phase methodology in
a number of different antigenic forms, for the purpose of comparing th
e effectiveness of different adjuvant-carrier systems in the induction
of a murine antibody response against the immunizing peptide and pare
nt antibody molecule. Two of the synthetic constructs contained the pa
lmitoyl and lmitoyl-cysteinyl-S-(2,3-palmitoyloxy)-propanediol (PAM(3)
Cys) moieties, respectively, attached to the peptide amino terminus wi
th the immunogen comprising liposomal formulations of each. A third im
munogen consisted of the CDR2 V-H peptide admired with the PAM(3)Cys n
on-covalently and incorporated into liposomes (PAM(3)Cys + CDR2 V-H).
A fourth composition comprised the CDR2 V-H peptide conjugated to KLH
via the sulfhydryl of an added N terminal cysteine (KLH-CDR2 V-H) and
injected with Complete Freund's adjuvant (CFA). A fifth immunogen cons
isted of the CDR2V(H) peptide synthesized on an octameric, branched po
lylysine core as a multiple antigenic peptide (MAP-CDR2 V-H) injected
in the presence of Freund's adjuvant. Groups of five mice were injecte
d intramuscularly with each of these immuno ens and bled at two week i
ntervals. The highest anti-peptide gamma-immunoglobulin (IgG) response
s (against uncoupled peptide by ELISA) after 56 days were obtained wit
h mice receiving the PAM(3)Cys-CDR2 V-H peptide. However, when screene
d against the CDK2 V-H peptide present as the MAP derivative by ELISA,
IgG raised against the cognate MAP-CDR2 peptide was much more reactiv
e than IgG raised against the liposomal PAM(3)Cys-CDR2 V-H immunogen.
In either case, IgG raised against the KLH-CDR2 V-H conjugate was poor
ly reactive. These differences in reactivity to the two forms of the C
DR2 V-H peptide by ELISA did not correspond to major differences in re
activities to the intact L202 Ab by ELISA. Although the IgG against th
e MAP immunogen was slightly more reactive than the other antisera aga
inst the L202 Ab, all titers were less than 1:100. These data illustra
te some limitations of using anti-peptide responses as indicators of p
otential reactivity against the native protein, but suggest that alter
nate formulations including lipoidal peptides are more effective than
corresponding KLH-peptide conjugates in eliciting Ab responses against
poorly immunogenic epitopes.